P01-CA-55165/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1994	3
1995	3
1997	4
1998	1
2024	0

1

Synthesis and cytotoxic activity of indolyl thiazoles.

Moody CJ, Roffey JR, Stephens MA, Stratford IJ. Moody CJ, et al. Anticancer Drugs. 1997 Jun;8(5):489-99. doi: 10.1097/00001813-199706000-00012. Anticancer Drugs. 1997. PMID: 9215613

2

Targeting gene expression to hypoxic tumor cells.

Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ, Harris AL. Dachs GU, et al. Nat Med. 1997 May;3(5):515-20. doi: 10.1038/nm0597-515. Nat Med. 1997. PMID: 9142119

3

Synthesis and biological activity of thiazolylindolequinones, analogues of the natural product BE 10988.

Moody CJ, Swann E, Houlbrook S, Stephens MA, Stratford IJ. Moody CJ, et al. J Med Chem. 1995 Mar 17;38(6):1039-43. doi: 10.1021/jm00006a024. J Med Chem. 1995. PMID: 7699696

4

Enhancement of bioreductive drug toxicity in murine tumours by inhibition of the activity of nitric oxide synthase.

Butler SA, Wood PJ, Cole S, Williams C, Adams GE, Stratford IJ. Butler SA, et al. Br J Cancer. 1997;76(4):438-44. doi: 10.1038/bjc.1997.407. Br J Cancer. 1997. PMID: 9275019 Free PMC article.

5

Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.

Patterson AV, Saunders MP, Chinje EC, Talbot DC, Harris AL, Strafford IJ. Patterson AV, et al. Br J Cancer. 1997;76(10):1338-47. doi: 10.1038/bjc.1997.558. Br J Cancer. 1997. PMID: 9374381 Free PMC article.

6

The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233).

Patterson AV, Robertson N, Houlbrook S, Stephens MA, Adams GE, Harris AL, Stratford IJ, Carmichael J. Patterson AV, et al. Int J Radiat Oncol Biol Phys. 1994 May 15;29(2):369-72. doi: 10.1016/0360-3016(94)90291-7. Int J Radiat Oncol Biol Phys. 1994. PMID: 8195035

7

Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia.

Robertson N, Haigh A, Adams GE, Stratford IJ. Robertson N, et al. Eur J Cancer. 1994;30A(7):1013-9. doi: 10.1016/0959-8049(94)90134-1. Eur J Cancer. 1994. PMID: 7946565

8

Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233).

Patterson AV, Barham HM, Chinje EC, Adams GE, Harris AL, Stratford IJ. Patterson AV, et al. Br J Cancer. 1995 Nov;72(5):1144-50. doi: 10.1038/bjc.1995.478. Br J Cancer. 1995. PMID: 7577460 Free PMC article.

9

Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivo.

Naylor MA, Adams GE, Haigh A, Cole S, Jenner T, Robertson N, Siemann D, Stephens MA, Stratford IJ. Naylor MA, et al. Anticancer Drugs. 1995 Apr;6(2):259-69. doi: 10.1097/00001813-199504000-00010. Anticancer Drugs. 1995. PMID: 7795274

10

Cyclopropamitosenes, novel bioreductive anticancer agents. Synthesis, electrochemistry, and biological activity of 7-substituted cyclopropamitosenes and related indolequinones.

Cotterill AS, Moody CJ, Mortimer RJ, Norton CL, O'Sullivan N, Stephens MA, Stradiotto NR, Swann E, Stratford IJ. Cotterill AS, et al. J Med Chem. 1994 Oct 28;37(22):3834-43. doi: 10.1021/jm00048a019. J Med Chem. 1994. PMID: 7966141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year